Ya‐Chen Lin

589 total citations
17 papers, 350 citations indexed

About

Ya‐Chen Lin is a scholar working on Neurology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ya‐Chen Lin has authored 17 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ya‐Chen Lin's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (5 papers) and Genetic Neurodegenerative Diseases (3 papers). Ya‐Chen Lin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (5 papers) and Genetic Neurodegenerative Diseases (3 papers). Ya‐Chen Lin collaborates with scholars based in United States, United Kingdom and Spain. Ya‐Chen Lin's co-authors include Daniel O. Claassen, Hakmook Kang, Paula Trujillo, Kalen J. Petersen, Manus J. Donahue, Alexander M. Lopez, Ciaran Considine, Yan Yan, Colin D. McKnight and David H. Zald and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Ya‐Chen Lin

17 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya‐Chen Lin United States 10 191 189 88 63 43 17 350
Alexander M. Lopez United States 9 132 0.7× 124 0.7× 68 0.8× 60 1.0× 22 0.5× 24 269
Xiaoyan Bai China 11 75 0.4× 108 0.6× 98 1.1× 38 0.6× 51 1.2× 40 316
C. Benito Spain 11 57 0.3× 81 0.4× 73 0.8× 46 0.7× 104 2.4× 21 309
Leon P. Munting Netherlands 9 121 0.6× 101 0.5× 66 0.8× 17 0.3× 27 0.6× 11 265
Maiken K. Brix Norway 5 52 0.3× 104 0.6× 47 0.5× 21 0.3× 57 1.3× 6 186
Albert Stezin India 11 233 1.2× 109 0.6× 53 0.6× 12 0.2× 40 0.9× 49 364
Stephanie Assuras United States 8 107 0.6× 115 0.6× 10 0.1× 69 1.1× 26 0.6× 16 272
Robin Corkill United Kingdom 10 173 0.9× 70 0.4× 83 0.9× 13 0.2× 18 0.4× 16 330
Kemeng Zhang China 5 146 0.8× 290 1.5× 78 0.9× 102 1.6× 14 0.3× 11 346
Jawad A. Bajwa Saudi Arabia 11 300 1.6× 164 0.9× 17 0.2× 49 0.8× 99 2.3× 20 410

Countries citing papers authored by Ya‐Chen Lin

Since Specialization
Citations

This map shows the geographic impact of Ya‐Chen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Chen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Chen Lin more than expected).

Fields of papers citing papers by Ya‐Chen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Chen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Chen Lin. The network helps show where Ya‐Chen Lin may publish in the future.

Co-authorship network of co-authors of Ya‐Chen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Chen Lin. A scholar is included among the top collaborators of Ya‐Chen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Chen Lin. Ya‐Chen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lin, Ya‐Chen, et al.. (2025). Meeting enrollment targets in IMbrave152/SKYSCRAPER-14, a global phase 3 study in patients with unresectable hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 43(16_suppl). 1585–1585. 1 indexed citations
2.
Paz‐Ares, Luis, Stephen V. Liu, Solange Peters, et al.. (2025). Lurbinectedin (lurbi) + atezolizumab (atezo) as first-line (1L) maintenance treatment (tx) in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC): Primary results of the phase 3 IMforte trial.. Journal of Clinical Oncology. 43(16_suppl). 8006–8006. 2 indexed citations
3.
Badhrinarayanan, Shreya, et al.. (2024). IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma. Future Oncology. 20(28). 2049–2057. 13 indexed citations
4.
Bermudez, Camilo, Karthik Ramadass, Eric Farber‐Eger, et al.. (2024). Volumetric brain MRI signatures of heart failure with preserved ejection fraction in the setting of dementia. Magnetic Resonance Imaging. 109. 49–55. 3 indexed citations
5.
Stark, Adam, Kalen J. Petersen, Ya‐Chen Lin, et al.. (2023). Accentuated Paralimbic and Reduced Mesolimbic D2/3-Impulsivity Associations in Parkinson's Disease. Journal of Neuroscience. 43(50). 8733–8743. 1 indexed citations
6.
Berkowitz, Sean T., et al.. (2021). Clinical implications of photophobia in progressive supranuclear palsy. Clinical Parkinsonism & Related Disorders. 4. 100097–100097. 3 indexed citations
7.
Trujillo, Paula, et al.. (2021). Symptoms of Medication Withdrawal in Parkinson’s Disease: Considerations for Informed Consent in Patient-Oriented Research. Pharmaceutical Medicine. 35(3). 163–167. 1 indexed citations
8.
Pfalzer, Anna C., Kelly H. Watson, Ya‐Chen Lin, et al.. (2021). Healthcare Delivery and Huntington’s Disease During the Time of COVID-19. Journal of Huntington s Disease. 10(2). 313–322. 9 indexed citations
9.
McKnight, Colin D., Paula Trujillo, Alexander M. Lopez, et al.. (2021). Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease. Parkinsonism & Related Disorders. 89. 98–104. 107 indexed citations
10.
Goldstein, Jody, et al.. (2020). Empowering the Clinical Research Coordinator in Academic Medical Centers. SHILAP Revista de lepidopterología. 5(2). 265–273. 18 indexed citations
11.
Lopez, Alexander M., Paula Trujillo, Ya‐Chen Lin, et al.. (2020). Structural Correlates of the Sensorimotor Cerebellum in Parkinson's Disease and Essential Tremor. Movement Disorders. 35(7). 1181–1188. 25 indexed citations
12.
Stark, Adam, et al.. (2020). Self‐reported rates of impulsivity in Parkinson’s Disease. Annals of Clinical and Translational Neurology. 7(4). 437–448. 11 indexed citations
13.
Trujillo, Paula, Kalen J. Petersen, Matthew J. Cronin, et al.. (2019). Quantitative magnetization transfer imaging of the human locus coeruleus. NeuroImage. 200. 191–198. 29 indexed citations
14.
Diehl, Sarah, Antje S. Mefferd, Ya‐Chen Lin, et al.. (2019). Motor speech patterns in Huntington disease. Neurology. 93(22). e2042–e2052. 19 indexed citations
15.
Stark, Adam, Christopher T. Smith, Ya‐Chen Lin, et al.. (2018). Nigrostriatal and Mesolimbic D2/3Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors. Journal of Neuroscience. 38(13). 3230–3239. 37 indexed citations
16.
Juttukonda, Meher R., Giulia Franco, Dario J. Englot, et al.. (2018). White matter differences between essential tremor and Parkinson disease. Neurology. 92(1). e30–e39. 33 indexed citations
17.
Petersen, Kalen J., Adam Stark, Ya‐Chen Lin, et al.. (2017). Ventral striatal network connectivity reflects reward learning and behavior in patients withParkinson's disease. Human Brain Mapping. 39(1). 509–521. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026